Lurasidone for the treatment of schizophrenia: pooled analysis of short-term, placebo-controlled trials

被引：0
|
作者：
Murthy, V. [1 ]
Cucchiaro, J. [2 ]
Pikalov, A. [3 ]
Xu, J. [2 ]
Loebel, A. [3 ]
机构：
[1] Takeda Dev Ctr Europe, Clin Dev, London, England
[2] Sunovion Pharmaceut Inc, Clin Dev, Ft Lee, NJ 07024 USA
[3] Sunovion Pharmaceut Inc, Clin Dev & Med Affairs, Ft Lee, NJ 07024 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70769-7
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.046
引用
下载
收藏
页码：S485 / S486
页数：2
相关论文
共 50 条
  • [1] Safety of Lurasidone in Older Adults with Schizophrenia: A Pooled Analysis of Short-Term Placebo-Controlled Studies
    Potkin, Steven
    Tocco, Michael
    Pikalov, Andrei
    Hsu, Jay
    Cucchiaro, Josephine
    Loebel, Antony
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S552 - S553
  • [2] Effect of lurasidone on weight and metabolic parameters : Results from pooled short-term placebo-controlled trials in schizophrenia
    Pikalov, A.
    Silva, R.
    Cucchiaro, J.
    Hsu, J.
    Xu, J.
    Loebel, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 124 - 125
  • [3] Efficacy and safety of lurasidone in male and female patients with schizophrenia: a pooled analysis of short-term, placebo-controlled studies
    Perkins, D.
    Tocco, M.
    Pikalov, A.
    Hsu, J.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S569 - S569
  • [4] Efficacy of Lurasidone in Patients With Schizophrenia With Prominent Positive Symptoms: A Pooled Analysis of Short-Term Placebo-Controlled Studies
    Potkin, Steven G.
    Tocco, Michael
    Mao, Yongcai
    Cucchiaro, Josephine
    Loebel, Antony
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 201 - 201
  • [5] Efficacy of lurasidone across five symptom dimensions of schizophrenia: Pooled analysis of short-term, placebo-controlled studies
    Loebel, A.
    Cucchiaro, J.
    Silva, R.
    Mao, Y.
    Xu, J.
    Pikalov, A.
    Marder, S. R.
    EUROPEAN PSYCHIATRY, 2015, 30 (01) : 26 - 31
  • [6] Efficacy of lurasidone in patients with schizophrenia with prominent positive symptoms: a pooled analysis of short-term placebo-controlled studies
    Potkin, S.
    Tocco, M.
    Mao, Y.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S562 - S563
  • [7] Safety of lurasidone: Pooled analysis of five placebo-controlled trials in patients with schizophrenia
    Cucchiaro, J.
    Pikalov, A.
    Ogasa, M.
    Silva, R.
    Hsu, J.
    Xu, J.
    Loebel, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 217 - 217
  • [8] Efficacy of lurasidone in schizophrenia : Factor analysis of pooled short-term trials
    Cucchiaro, J.
    Silva, R.
    Mao, Y.
    Pikalov, A.
    Loebel, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 125 - 125
  • [9] EFFECT OF LURASIDONE ON WEIGHT AND METABOLIC PARAMETERS: RESULTS FROM POOLED SHORT-TERM PLACEBO-CONTROLLED AND LONG-TERM EXTENSION TRIALS IN SCHIZOPHRENIA
    Pikalov, Andrei
    Cucchiaro, Josephine
    Ogasa, M.
    Silva, Robert
    Hsu, J.
    Xu, J.
    Loebel, Antony
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 317 - 317
  • [10] Efficacy of lurasidone in schizophrenia: pooled analysis of the five PANSS factors in short-term trials
    Werner, P.
    Cucchiaro, J.
    Silva, R.
    Pikalov, A.
    Mao, Y.
    Loebel, A.
    Marder, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S341 - S341
12345